Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $45

Benzinga Newsdesk www.benzinga.com Negative 67.7%

Neg 67.7% Neu 0% Pos 0%

Canaccord Genuity analyst Luke Morison maintains Concentrix (NASDAQ:CNXC) with a Buy and lowers the price target from $55 to $45.